Titan Pharmaceuticals Report issue

For profit Phase 2 Phase 3
Founded: South San Francisco CA United States (1992)

Organization Overview

First Clinical Trial
2000
NCT00761436
First Marketed Drug
2016
buprenorphine
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Titan Pharmaceuticals | TITAN PHARMS